CME Group Announces Leadership Transition

TL;DR

Duffy steps down as President, Ryan takes over. No major shockwaves expected.

AI Summary

CME Group Inc. announced on March 7, 2024, that Terrence A. Duffy will transition from Executive Chairman and President to Executive Chairman, effective March 11, 2024. Concurrently, John W. Ryan will assume the role of President, in addition to his current position as Chief Executive Officer. These changes are part of the company's succession planning.

Why It Matters

This leadership transition at CME Group, a major financial market operator, could signal shifts in strategic direction or operational focus under new presidential leadership.

Risk Assessment

Risk Level: low — The changes are part of a planned succession and do not indicate any financial distress or unexpected events.

Key Players & Entities

• CME Group Inc. (company) — The company filing the report.
• Terrence A. Duffy (person) — Outgoing President and current Executive Chairman.
• John W. Ryan (person) — Incoming President and current Chief Executive Officer.
• March 11, 2024 (date) — Effective date of Terrence A. Duffy's role change.
• March 7, 2024 (date) — Date of the report filing.
• March 4, 2024 (date) — Date of the earliest event reported.

FAQ

From the Filing

0001193125-24-062191.txt : 20240307 0001193125-24-062191.hdr.sgml : 20240307 20240307161537 ACCESSION NUMBER: 0001193125-24-062191 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240304 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 02 Finance IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 24730304 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 d14382d8k.htm 8-K 8-K false 0001156375 0001156375 2024-03-04 2024-03-04     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) March 7, 2024 ( March 4, 2024 )     CME GROUP INC. (Exact Name of Registrant as Specified in its Charter)       Delaware   001-31553   36-4459170 (State or Other Jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.)   20 South Wacker Drive   Chicago   Illinois   60606 (Address of Principal Executive Offices)       (Zip Code) Registrant’s telephone number, including area code: (312)   930-1000 N/A (Former Name or Former Address, if Changed Since Last Report)     Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Class A Common Stock   CME   Nasdaq Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. CME Group Omnibus Stock Plan On March 4, 2024, the Compensation Committee (the “Committee”) of CME Group Inc. (“CME Group” or the “Company”) approved an amended and restated Omnibus Stock Plan (the “Amended Omnibus St